A. Fayet-Mello

The Candidate Blood-stage Malaria Vaccine P27A Induces a Robust Humoral Response in a Fast Track to the Field Phase 1 Trial in Exposed and Nonexposed Volunteers

F. Spertini, S. Abdulla, B. Genton, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals

A. Telenti, H. Günthard, T. Buclin, 2013, Pharmacogenetics and genomics.

Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals.

A. Telenti, T. Buclin, B. Ledergerber, 2014, The Journal of antimicrobial chemotherapy.

A randomized crossover study to compare efavirenz and etravirine treatment

E. Bernasconi, B. Hirschel, M. Cavassini, 2011, AIDS.

Free and Total Plasma Levels of Lopinavir during Pregnancy, at Delivery and Postpartum: Implications for Dosage Adjustments in Pregnant Women

A. Telenti, T. Buclin, J. Biollaz, 2012, Antiviral therapy.

Population Pharmacokinetic Analysis and Pharmacogenetics of Raltegravir in HIV-Positive and Healthy Individuals

A. Telenti, H. Günthard, T. Buclin, 2012, Antimicrobial Agents and Chemotherapy.

Rivastigmine for HIV-associated neurocognitive disorders

J. Annoni, B. Hirschel, E. Giacobini, 2013, Neurology.

Population Pharmacokinetic Analysis and Pharmacogenetics

A. Telenti, T. Buclin, M. Aouri, 2012 .

A randomized crossover study to compare efavirenz and etravirine treatment

E. Bernasconi, B. Hirschel, M. Cavassini, 2011, AIDS.

Randomized, double-blind, controlled phase 1 trial of the candidate tuberculosis vaccine ChAdOx1-85A delivered by aerosol versus intramuscular route.

O. Karoui, R. Audran, A. Fayet-Mello, 2024, The Journal of infection.